Aquestive Share Price

Aquestive Share Price

NASDAQ: AQST | Small Cap | Healthcare
$3.47
-$0.22 (-5.96%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Aquestive Stock Performance

Open
$3.64
Prev. Close
$3.69
Circuit Range
N/A
Day Range
$3.41 - $3.64
Year Range
$2.93 - $6.73
Volume
1,04,823
Average Traded
$3.49

Aquestive Share Price Today

As of 22 November 2026, Aquestive Therapeutics, Inc.'s share price is $3.47. The stock opened at $3.64, compared to its previous close of $3.69. During today's trading session, Aquestive Therapeutics, Inc.'s share price traded between $3.41 and $3.64, with an average price of $3.53. Over the past 52 weeks, the stock has recorded a high of $6.73 and a low of $2.93. In terms of performance, Aquestive Therapeutics, Inc.'s share price has declined by 13.90% over the last six months and is down 43.99% on a year-on-year basis.

Aquestive Share Price Chart

Line chart of the Aquestive price trend over the selected period. The price fell overall, ranging from 3.42 to 3.64, ending at 3.47.
$3.41$3.64
L
Show Current Price
H

Aquestive Stock Fundamentals & Key Indicators

Market Cap
$371.04M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.63
Revenue (TTM)
$44.55B
Return On Equity (TTM)
111.94%
Profit Margin
-188.06%
Debt to Equity
-0.72
Quarterly Earnings Growth YoY
48.21%

Aquestive Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$13.02$14.45$13.82$7.56
Net Profit-$31.86-$8.06-$22.86-$16.50
Net Profit Margin-244.70%-55.78%-165.41%-218.25%
Income ChangeN/A74.70%-183.62%27.82%

Aquestive Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$47.68$50.58$57.56$44.55
Net Profit-$54.41-$7.87-$44.14-$83.78
Net Profit Margin-114.11%-15.56%-76.69%-188.06%
Income ChangeN/A85.54%-460.86%-89.81%

Aquestive Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets11.1613.216.4517.18
Current Assets149.2788.2240.9739.89
Total Assets160.43101.4257.4257.07
Non Current Liabilities146.48142.72145.6136.1
Current Liabilities47.6118.8718.3139.53
Total Liabilities194.09161.58163.91175.62
Shareholders' Equity-33.66-60.16-106.49-118.55

Aquestive Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-52.43-35.76-6.38-9.82
Investing-0.56-0.16-1.0-2.52
Financing102.6283.593.9711.59

About Aquestive

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Aquestive Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.95
$3.46
-10.95%
Oct 2026
$4.60
$3.88
-16.11%
Sep 2026
$5.13
$4.63
-10.11%
Aug 2026
$3.67
$5.14
+39.05%
Jul 2026
$4.26
$3.70
-11.38%
Jun 2026
$3.99
$4.17
+3.60%
May 2026
$4.13
$4.03
-1.83%
Apr 2026
$4.19
$4.11
-1.08%
Mar 2026
$4.02
$4.15
+2.98%
Feb 2026
$4.00
$4.03
+37.54%
Jan 2026
$6.57
$2.93
-54.57%
Dec 2025
$6.07
$6.45
+4.12%

Aquestive Share Price FAQs